Results 221 to 230 of about 316,264 (317)

Dermatology.

, 1906
J A Nixon
openalex   +1 more source

Effect of a Home‐Based Exercise Program on Muscle Mass, Fatigue, and Health‐Related Quality of Life Among Patients with Oral Cancer: A Randomized Trial

Head &Neck, EarlyView.
ABSTRACT Background Patients with head and neck cancer (HNC) often experience deteriorated health‐related quality of life (HRQoL) and loss of body weight and muscle mass. The primary aim was to determine if a home‐based exercise program, aiming to increase physical activity (PA), could reduce muscle mass loss and fatigue.
Camilla Wallmander, Ingvar Bosaeus, Ewa Silander, Hedda Haugen Cange, Jan Nyman, Monika Fagevik Olsén, Elisabet Blomsterwall, Malin Berg, Eva Hammerlid   +8 more
wiley   +1 more source

Dermatologic Patterns and Psychological Drivers of Factitious Dermatitis in Adolescent Females

Nicole Werpachowski, Bret-Ashleigh Gray, Nahleh Koochak, Julia Vinagolu-Baur, Kelly Frasier, Alina G. Bridges   +5 more
openalex   +1 more source

Patient‐Reported Dysphagia and Swallowing‐Related Quality of Life up to 10 Years After (Chemo)radiotherapy for Head and Neck Cancer: A Cross‐Sectional Study

Head &Neck, EarlyView.
ABSTRACT Background This study sought to better understand patient‐reported dysphagia and swallowing‐related quality of life (swQOL) in patients 6 months to 10 years following definitive (chemo)radiotherapy for head and neck cancer (HNC). Methods In this cross‐sectional study, self‐reported dysphagia was assessed with the Eating Assessment Tool (EAT‐10)
Jacqui J. Frowen, Allison Drosdowsky, Tsien F. Fua, Lachlan J. McDowell, Karla Gough   +4 more
wiley   +1 more source

Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network. [PDF]

Cancers (Basel)
Blazejak C, Oymanns M, Stranzenbach R, Hillen U, Mitteldorf C, Nicolay JP, Wobser M, Schrüfer P, Gosmann J, Wehkamp U, Booken N, Kreuter A, Dippel E, Klemke CD, Weyermann M, Stadler R, Assaf C.   +16 more
europepmc   +1 more source

Loss of the Y Chromosome in Oral Potentially Premalignant Disorders Predicts Malignant Progression: An Integrative Cross‐Species Multi‐Cohort Bioinformatic Study

Head &Neck, EarlyView.
ABSTRACT Background The loss of the Y chromosome (LOY) and the extreme down‐regulation of Y chromosome gene expression (EDY) are frequently observed in oral squamous cell carcinoma (OSCC). However, their roles in oral potentially malignant disorders (OPMDs) are unclear.
Rui Han, Jos B. Poell, Cristina Conde‐Lopez, Tuula Salo, Ina Kurth, Ruud H. Brakenhoff, Jochen Hess   +6 more
wiley   +1 more source

Assessing public interest in artificial intelligence in dermatology: A Google Trends analysis. [PDF]

JID Innov
Yan MJ, Jiang YC, Wongvibulsin S, Chen ST.   +3 more
europepmc   +1 more source

Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma

Head &Neck, EarlyView.
ABSTRACT Purpose Olfactory neuroblastoma (ONB) is a rare sinonasal malignancy with limited therapeutic options in the recurrent/metastatic setting; little is known regarding its responsiveness to immunotherapy. Inhibition of enhancer of zeste homolog 2 (EZH2) has been shown to improve T‐cell‐mediated killing and susceptibility to immune checkpoint ...
Elisabetta Xue, Tolulope Adeyelu, Harris Krause, Andrew Elliott, Ranee Mehra, Heloisa Soares, Emil Lou, Ari Vanderwalde, David Spetzler, Dara Bracken‐Clarke, Nyall R. London Jr., James L. Gulley, Charalampos S. Floudas   +12 more
wiley   +1 more source

Health System Experiences and Care Engagement in Latine Patients With Hidradenitis Suppurativa. [PDF]

JAMA Dermatol
Hernandez Y, Gonzalez N, Ghanshani R, Castillo Valladares HB, Amerson EH, Naik HB, Hsiao JL, James J, Ackerman SL, Chang AY.   +9 more
europepmc   +1 more source

Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background The standard‐of‐care for advanced periauricular cutaneous squamous cell carcinoma (pCSCC) is surgery and adjuvant radiation therapy. Neoadjuvant immunotherapy recently demonstrated high pathologic response rates in patients with resectable pCSCC.
David Z. Allen, Neil Gross, Marc‐Elie Nader, Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, Paul Gidley   +6 more
wiley   +1 more source